Liver disease is invisible.
We make it visible.
Hepalens is an augmented reality liver application for pharmaceutical companies. It turns an invisible disease into something a patient can actually see: a living 3D liver, and what MASH does to it, stage by stage.
You cannot feel your liver. Most patients cannot picture it either.
Diseases like MASH (metabolic dysfunction-associated steatohepatitis) progress silently for years. Patients are told their liver is accumulating fat, becoming inflamed, scarring. Yet they feel nothing, see nothing, and are handed abstract numbers: enzyme levels, fibrosis stages, biopsy scores. What they cannot picture, they struggle to act on.
A silent disease, shown in seconds
Animation compresses years of invisible progression (steatosis, inflammation, fibrosis) into a sequence anyone can follow, in any language, at any level of health literacy.
Seeing beats being told
An interactive 3D liver a patient can turn in their own hands replaces abstraction with intuition. Words like "fibrosis" and "scarring" get a shape, and treatment gets a visible purpose.
Understanding drives outcomes
Patients who understand their disease engage differently with lifestyle change, therapy and clinical trials. For pharma, comprehension is not a soft goal: it shapes adherence and retention.
One liver, every stage of disease
Hepalens renders an anatomically grounded, interactive liver in augmented reality, right on the table in front of a patient, a physician or a congress audience. Walk through disease progression stage by stage, or focus on your therapy's mechanism of action.
Healthy liver
Baseline anatomy patients can explore and recognise as their own.
Steatosis
Fat accumulates silently. The first, still reversible step.
MASH & fibrosis
Inflammation and scarring set in, still invisible from outside.
Cirrhosis
What patients risk, and what timely treatment protects against.
Built for the moments where understanding decides
Hepalens is licensed directly to pharmaceutical companies, deliberately not distributed through public app stores. Medical, marketing and sales teams all work with the same controlled, compliant tool, tailored to your therapeutic story.
Medical & clinical teams
Patient education in clinics and trial settings: help patients grasp their diagnosis, the stakes and the role of therapy. Supports informed consent, adherence and trial retention, and gives MSLs a sharper tool for scientific exchange.
Marketing & brand teams
Turn disease awareness and brand campaigns into an experience: congress booths people queue for, launch events people remember, and a story that explains the science behind your therapy.
Sales teams
A door opener in every call: reps put the liver on the table and walk an HCP through disease and mechanism of action in minutes. More memorable than any leave behind.
From first demo to deployment
A deliberately simple engagement model. No app store dependency, no complicated rollout.
See it live
A 30 minute demo, remote or on site. Put the liver on your own conference table and judge the effect yourself.
Tailor it
We adapt content to your indication, molecule and markets, working alongside your medical, marketing and compliance teams.
Deploy it
Licensed directly to your organisation and provisioned on your devices: field teams, congresses, trial sites.
Show your team the liver they've been talking about
Tell us your indication and where you'd use it, from patient education to congress and field work, and we'll set up a demo. Based in Switzerland, working with pharma companies internationally.